When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?

The current use of chloroquine and/or hydroxychloroquine, a drug currently used to treat autoimmune rheumatic diseases, in treating severe acute respiratory syndrome caused by coronavirus 2 (SARSCoV-2) or COVID-19-infected patients with pneumonia is a matter of intense consideration. We wish to ente...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogdanos, Dimitrios P., Daniil, Zoi, Zakynthinos, Epaminondas, Gourgoulianis, Konstantinos, Sakkas, Lazaros I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219635/
https://www.ncbi.nlm.nih.gov/pubmed/32411941
http://dx.doi.org/10.31138/mjr.31.1.94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219635/
https://www.ncbi.nlm.nih.gov/pubmed/32411941
http://dx.doi.org/10.31138/mjr.31.1.94

Ejemplares similares